Health

Fauci warned it was too early to believe that the US had its COVID-19 situation under control


Dr Anthony Fauci (pictured), warned on Wednesday that it was too early to consider controlling the COVID-19 pandemic despite the recent drop in cases

Dr Anthony Fauci (pictured), warned on Wednesday that it was too early to consider controlling the COVID-19 pandemic despite the recent drop in cases

Dr Anthony Fauci (pictured), warned on Wednesday that it was too early to consider controlling the COVID-19 pandemic despite the recent drop in cases

Dr Anthony Fauci, the nation’s top infectious disease expert, warned on Wednesday that it was too early to consider Covid ‘under control’ in the US.

During Wednesday’s Covid briefing, the Director of the National Institute of Allergy and Infectious Diseases warned that the current Covid situation is not as optimistic as some officials and experts are saying.

In last year.

Omicron’s rapid spread, combined with the relatively mild nature of the variant, has many experts and officials hoping that the strain will be what turns the pandemic into an endemic disease.

Fauci is more generally pessimistic about the future of the pandemic than many other experts, although some of his more grim predictions have come true.

He also mentioned that the Pfizer-BioNTech vaccine for young children – which he believes could be out soon – will require three doses instead of the standard two-dose regimen.

Fauci also reaffirmed his confidence that the Pfizer vaccine will be made available to children under the age of 5 as early as next month.  The vaccine regimen will have three doses much smaller than those currently used in adults.  Pictured: A young girl in Cranston, Rhode Island, gets a shot of the COVID-19 vaccine in November 2021

Fauci also reaffirmed his confidence that the Pfizer vaccine will be made available to children under the age of 5 as early as next month.  The vaccine regimen will have three doses much smaller than those currently used in adults.  Pictured: A young girl in Cranston, Rhode Island, gets a shot of the COVID-19 vaccine in November 2021

Fauci also reaffirmed his confidence that the Pfizer vaccine will be made available to children under the age of 5 as early as next month. The vaccine regimen will have three doses much smaller than those currently used in adults. Pictured: A young girl in Cranston, Rhode Island, gets a shot of the COVID-19 vaccine in November 2021

‘We want where is enough control. It’s not eradication… that’s unreasonable. Not necessarily elimination… but a degree of control that doesn’t disrupt us in society,’ Fauci said.

‘It doesn’t dominate our lives and doesn’t stop us from doing the things we normally do in normal life.’

He added that the US is not there yet and it still records high daily case and death figures.

According to the most recent data from Johns Hopkins University, the US averages 639,723 cases per day – a 13% drop in the past week.

However, the death toll is on an upward trend, rising 28% over the past week to 2,259 per day.

However, he believes that a control point can be reached, and it will require the use of vaccines, masks, testing and antiretroviral treatment.

Vaccine eligibility could also be expanded soon. Fauci reiterated Wednesday that he thinks approvals for children under 5 will be approved as early as next month.

Pfizer, the company that makes the most commonly used shot in the US, plans to soon submit data to regulators on the three-dose vaccine used in children under the age of 5.

The photos will be significantly smaller. Adults and children over 12 years of age are currently receiving a dose of 30 micrograms of the vaccine, and children 5 to 12 years of age are receiving a dose of 10 micrograms.

The injection for children under 5 years of age would be 3 micrograms, one-third the size of the smallest dose available.

Antiviral Covid treatments, which help a person curb symptoms after an infection – unlike vaccines whose main job is to prevent infection – have been a topic of controversy for weeks recently.

Pfizer and Merck have both developed antiviral drugs that are easy to use and considered effective in preventing the most severe symptoms of Covid.

The White House has placed large orders for both drugs to be distributed to patients around the country, even though Pfizer’s Paxlovid is in short supply.

Jeff Zient, the White House response coordinator, assured the public that the drug would be available for use.

“We purchased 20 million courses of the Pfizer pill and we accelerated delivery of the first 10 million from September to the end of June,” he said.

‘We have hundreds of thousands of pills in the first quarter of 2022 each month, and that number will grow to millions to complete the first half of the 20 million by the end of June. “

The monoclonal antibody, a favorite of some Republicans like Florida Gov Ron DeSantis, has been halted in the US for the time being.

The Food and Drug Administration (FDA) has made the controversial decision to withdraw the licenses for two drugs made by Regeneron and Eli Lilly after data from the National Institutes of Health showed no effects against this strain of bacteria.

Monoclonal antibody drugs are expensive and resource-intensive to use, and the move was made to prevent precious healthcare resources from being wasted.

DeSantis, unhappy with the decision, said on Tuesday that the Biden administration made the decision ‘without a single piece of clinical data to support its decision.’

Source: | This article originally belonged to Dailymail.co.uk



Source link

news7f

News7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button